Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...

Pathophysiology of Diabetes

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...

Diabetes Mellitus: Introduction

Diabetes Mellitus: Introduction

Diabetes mellitus consists of chronic metabolic disorders characterized by persistent hyperglycemia. This elevated blood glucose results from defects in insulin secretion, impaired insulin action, or both. Insulin, produced by pancreatic β-cells, is essential for maintaining glucose homeostasis by facilitating cellular glucose uptake for energy or storage. Disruptions in insulin production or function lead to glucose accumulation in the bloodstream, causing the clinical features and long-term...

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis

Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...

Diabetes Mellitus: Overview and Type I Subtype

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

Hyperglycemia

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The risk of acute infections in new users of antidepressants: An observational cohort study.

Journal of affective disorders·2024

Same author

The dynamic relationship between sleep and psychotic experiences across the early stages of the psychosis continuum.

Psychological medicine·2023

Same author

The need for cardiac surgery differential tariffs in Israel at the era of aging population and emerging technology: Importance of procedure type and patient complexity as assessed by EuroSCORE.

Israel journal of health policy research·2021

Same author

Effects of commercial metronidazole and metronidazole benzoate suspensions on food intake in chinchillas.

The Journal of small animal practice·2020

Same author

Million-year lag times in a post-orogenic sediment conveyor.

Science advances·2020

Same author

Comparing abundance distributions and range maps in spatial conservation planning for migratory species.

Ecological applications : a publication of the Ecological Society of America·2019

Same journal

[Pelvic floor in pregnancy and after child birth: recommendations of the AUG Committee. Expert correspondence no. 29 of 31 July 2009].

Gynakologisch-geburtshilfliche Rundschau·2010

Same journal

[Water birth: control of infection and contraindications. Expert correspondence no. 27 of 26 May 2009].

Gynakologisch-geburtshilfliche Rundschau·2010

Same journal

[Current treatment options in postpartum hemorrhage. Expert correspondence no. 26 of 26 May 2009. ].

Gynakologisch-geburtshilfliche Rundschau·2010

Same journal

[Off label use of drugs in obstetric gynecology. 23rd consensus of of experts 19 October 2007].

Gynakologisch-geburtshilfliche Rundschau·2010

Same journal

[Hyperreactive luteomas during pregnancy--symptoms and complications: a case report].

Gynakologisch-geburtshilfliche Rundschau·2010

Same journal

[Paget disease of the vulva: resolution after local treatment with imiquimod--report of a case and review of the literature].

Gynakologisch-geburtshilfliche Rundschau·2010

See all related articles

Search research articles

Related Experiment Video

Updated: Jun 12, 2026

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

[Gestational diabetes].

U Lang, D Fink, R Kimming

Gynakologisch-Geburtshilfliche Rundschau

|June 10, 2010

Summary

This summary is machine-generated.

Gestational diabetes mellitus (GDM) is pregnancy-onset glucose intolerance. Early diagnosis and standardized treatment are crucial for preventing adverse maternal and fetal outcomes, especially long-term health risks for the child.

More Related Videos

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Related Experiment Videos

Last Updated: Jun 12, 2026

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Monitoring Blood Glucose in Mouse Offspring After Intracytoplasmic Sperm Injection

Published on: May 17, 2024

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Area of Science:

Obstetrics and Gynecology
Endocrinology
Perinatal Medicine

Background:

Gestational diabetes mellitus (GDM) is defined as glucose intolerance first identified during pregnancy.
Incidence of GDM varies significantly based on population and diagnostic intensity.
GDM is a significant risk factor for adverse maternal and fetal outcomes during pregnancy and beyond.

Discussion:

The pathophysiology of GDM involves a direct correlation between maternal blood glucose levels and complication rates.
Complications arise in the pre-, peri-, and postpartum periods, impacting both mother and fetus.
Understanding this association is key to mitigating risks.

Key Insights:

Maternal hyperglycemia during pregnancy is strongly linked to increased complication rates.
Adverse outcomes affect the mother, fetus, and can persist throughout their lifespans.
The pathophysiological basis highlights the critical window of pregnancy for intervention.

Outlook:

Standardized diagnostic criteria and therapy are essential for optimal GDM management.
Implementing well-defined morbidity criteria will improve patient care.
Focusing on standardized approaches is crucial for minimizing long-term and lifetime risks for the unborn child.